Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Investors’ sneak peek at biotech’s bright future
Health & Biotech
ASX Health Stocks: Island to tackle deadly Ebola virus
News
CLOSING BELL: ASX showing signs of a hangover on bumpy New Financial Year day
News
Closing Bell: Iceni Gold skyrockets 300pc on ‘spectacular discovery’; Perpetual to split up
Health & Biotech
ASX Health Stocks: Polynovo notches record month, Island Pharma gets much needed cash for Phase 2a trial
Health & Biotech
Which ASX companies are resurrecting abandoned drugs? Part 2
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX crushed with all 11 sectors deep in the red, but there’s some good news from China
Health & Biotech
ASX Health Stocks: Island Pharma releases data on dengue fever drug, IDT signs $3m+ deal with Sanofi
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Next Science jumps almost 10pc after XPERIENCE study published in science journal
Health & Biotech
ASX Health Stocks: Island Pharma advances anti-viral study; Compumedics scores $9.3m order in China
Health & Biotech
“Market is going to be surprised” as Firebrick Pharma set to launch antiviral nasal spray, Nasodine
Health & Biotech
ASX Health Stocks: Clarity Pharma, Island Pharma set to embark on next steps of clinical trials
Health & Biotech
ASX Health Stocks: Island Pharma granted Aussie patent for flavivirus infection drug, ISLA-101
Health & Biotech
ASX Health Stocks: Starpharma jumps 30pc after cancer drug helps enable ‘100 per cent’ control rate
Health & Biotech
